UNSPSC 51151621: Benzilone or benzilonium

This classification denotes an antimuscarinic agent with the molecular formula C22H28NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GY56LQX77B, chemically known as 1,1-diethyl-3-hydroxypyrrolidinium bromide benzilate but generally known as benzilone, which bears US NIH Compound Identifier 66247. European Medicines Agency schedules Benzilonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00722MIG.

World Health Organization schedules benzilone in its Anatomical Therapeutic Chemical (ATC) Classification. Benzilone or benzilonium bears US NLM identifiers UMLS ID C2828307 and NCI Concept Code C87444. SMILES: CC[N+]1(CCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)CC.[BR-].

UNSPSC 51151621 Benzilone or benzilonium is a Commodity code with minimal recent state and local procurement activity directly aligned to its chemical specification. The single relevant recent solicitation—Seminole County, Florida's IFB60459723LAS for Naloxone and Drug Deactivation Systems—does not target benzilone specifically but rather naloxone-based emergency medical supplies and drug disposal equipment for community health support. State and local governments use codes in this family to procure specialty pharmaceutical intermediates, chemical reagents, and active pharmaceutical ingredients, though the actual buying patterns under this specific code remain unclear from current market activity. The Seminole County opportunity represents a public-health-oriented procurement by a county health department rather than a traditional chemical or pharmaceutical bulk-purchase scenario.

The Texas Health and Human Services Commission's RFI HHS0017013 on direct-to-manufacturer prescriptions, posted April 3, 2026, signals state-level interest in pharmacy supply-chain restructuring but does not target benzilone as a line item or chemical ingredient. Recent activity is concentrated in Florida and Texas, but the geographic spread and issuing-body composition for this code cannot be reliably characterized from the available data. No other state or local jurisdictions appear in the current opportunities block. The code shows sparse recent activity, and the opportunities on file do not consistently align with procurement of benzilone or closely related chemical intermediates; further market intelligence may be required to assess whether this code reflects active demand or is primarily used as a catch-all classification for pharmaceutical-stage chemicals in state and local procurement systems.